Ezra Cohen, MD, associate director, Moores Cancer Center at the University of California, San Diego, discusses the treatment era before immunotherapy in head and neck cancer.
Before PD-1/PD-L1 inhibitors came into the mix, there were very limited options i
Kia ora tatou,
The latest newsletter includes a full update on the Northern Regional Project to improve head and neck cancer services in the region.
You can read it all by clicking the link below.
This week our news from around the world includes Sterling K. Brown interviewing cancer survivors, a reminder about HPV and an interview acknowledging the long-term and late effects of treatment.
Sterling K. Brown is embarking on a passion project. And, much like his NBC hit This Is Us, it shines light on difficult topics.
The two-time Emmy-winning actor partnered with Bristol-Myers Squibb for a serie
Kia ora tatou,
Network News
Head and Neck Cancer Community Concerns
In an Open Letter our Chair, Diana Ayling, addresses community concerns that have arisen over the last year. As the New Zealand health system faces significant pressures, it is important we as a community work collaboratively together, with one voice. Putting the past behind us is part of that process. Click here to read more....
Annual Members Survey Results
The Network carries out a Members Survey each year. We recently compl
Kia ora tatou,
This is me, and my friend Hazel. In 2011 we were on the Derwent river, Hobart, Australia. We were on our way to see MONA, the Museum of Old and New Art. We had just presented our paper at the ASCILITE conference, Thinking, researching and living in virtual professional development community of practice.
We were thrilled that our paper was well received. We were further delighted, when a respected Italian academic invited to write a book chapter in her upcoming book. In 2013,
This week we have news from New Zealand research into head and neck cancer, a brave survivor speaks about the signs and symptoms of head and neck cancer, and we introduce you to a life saving technology - the Gamma Knife. Enjoy...
This story was originally published on Newsroom.co.nz and is republished with permission.
From the Bay of Islands to Brussels there's a call to take a fresh look at old drugs to see if they could treat cancer for a fr
Kia ora tatou,
Network News
The Network has a new Board for the 2019/20 year. Diana Ayling (Chair), Heather Anderson (Secretary), and Board Members, Monica Koia, Brian Sheppard, and Gaynor Anderson. We elected to change the name of the “Committee” to “Board” and to allow online voting for any meeting of members. You can access the Minutes of the AGM here.
The Board is committed to two projects in the year ahead. We will be focusing on bringing the head and neck cancer community in New Zealand to
This week our Weekly Wednesday includes one man's struggles with the DHB system, new research indicates that HBO has limited benefits, researchers at MD Anderson Cancer Centre find some persistent aspects to HPV following treament and Lynn Aspey, explores "the new normal". Enjoy!
This week our Network News covers a great new podcast from our friends in Australia, new developments in immunotherapy, Ellen Goodman gives you the maths on starting the conversation about End of Life Care, and finally some data on the rise of head and neck cancers.
The Thing About Cancer
Listen to the welcome episode to find out what The Thing About Cancer podcast series is all about – and how it can help after a cancer diagnosis.
Get information and insights as host Julie McCrossin chats to e
This week our Network News is all about our Network. The AGM is to be held Monday 6 May at 6pm at Domain Lodge, Grafton, Auckland. Please check the details on our website. Patients, friends and family are most welcome to attend. It is an opportunity for members and prospective members to get together to discuss the performance of the Network over the year, and to plan for the year ahead.
What is you cannot attend in person?
You can attend our meeting by accessing it through Zoom technology onl
Quote from the article link shown below:
For example, Bell describes a study published by Southwick and colleagues in BMJ Quality & Safetyin which they analyzed patient reports following medical
There are many myths associated with head and neck cancer such as how environmental influences can affect our risk, or what role gender plays. Here, Dr Fauzia Riaz helps set the record straight to provide the real facts behind the myt
From our representative Heather Anderson.
The Thursday afternoon sessions started with Prof David Currow (Cancer Institute NSW, Australia) talking about prioritisation experiences in cancer control in Australia – in particular hubs of excellence. See his presentation here.
Hon Steve Maharey, the new Chair of PHARMAC, talked on the processes of PHARMAC – my personal take was that he used his “newness” to avoid the hard questions. There was an item of interest that he talked on which was a new d
Clinicians who prescribe radiation to treat cancer face a fundamental difficulty in determining what dose to apply: They don’t know how individual tumors will respond to the therapy.
Now, a project by researchers at the University of Arkansas and Johns Hopkins University may promise a way to detect the difference between tumors in the lung and the head and neck that react positively to the therapy, by shrinking, and those
Kia ora tatou,
Stand with our brothers and sisters affected by lung cancer. More New Zealand die of lung cancer than any other cancer. Sufferers are often stigmatised by smoking, when most have never smoked. The Lung Cancer Foundation are looking for support for their petition to have lung cancer declared a health priorty and to approve additional budget for Pharmac to fund lung cancer medications, including Keytruda, Alectinib, Osimertinib and Crizotinib, for all Kiwis with advanced lung cancer
